Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Entasis
Biotech
‘Potential game changer’ gonorrhea antibiotic meets standard
An antibiotic from GARDP and Innoviva Specialty Therapeutics has met the standard-of-care for gonorrhea, hitting the bullseye of a pivotal phase 3.
Gabrielle Masson
Nov 2, 2023 11:20am
Innoviva buys AstraZeneca antibiotic spinout Entasis
May 23, 2022 11:20am
Entasis antibiotic beats last resort treatment in phase 3 trial
Oct 19, 2021 10:35am
AstraZeneca spinout Entasis nabs Shire exec as CMO
Nov 1, 2019 7:47am
Novo Holdings' antibiotic resistance fund backs 3 biotechs
Jan 21, 2019 7:41am
AstraZeneca spinout Entasis files for $86M IPO
Aug 20, 2018 7:30am
